Nephrocare Health Services IPO Listing Date, GMP In Focus Ahead Of D-Street Debut

Key Highlights

• Nephrocare Health IPO was oversubscribed 13.96 times on the final bidding day.
• The IPO received bids for approximately 18.68 million shares against 1.33 million shares available.
• Qualified Institutional Buyers (QIBs) subscribed 27.47 times, while Non-Institutional Investors (NIIs) subscribed 24.27 times.
• Retail investor segment was oversubscribed 2.31 times.
• The shares are expected to open with potential gains of up to 9%.